Garofalo Health Care Stock Short Ratio
| GHC Stock | EUR 4.87 0.02 0.41% |
Garofalo Health Care fundamentals help investors to digest information that contributes to Garofalo Health's financial success or failures. It also enables traders to predict the movement of Garofalo Stock. The fundamental analysis module provides a way to measure Garofalo Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Garofalo Health stock.
Garofalo |
Garofalo Health Care Company Short Ratio Analysis
Garofalo Health's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Garofalo Health Care has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Medical Care Facilities (which currently averages 0.0) industry. The short ratio for all Germany stocks is 100.0% higher than that of the company.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Garofalo Fundamentals
| Return On Equity | 0.0851 | |||
| Return On Asset | 0.0425 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 467.88 M | |||
| Shares Outstanding | 89.09 M | |||
| Shares Owned By Insiders | 64.49 % | |||
| Shares Owned By Institutions | 21.72 % | |||
| Price To Earning | 40.71 X | |||
| Price To Book | 1.22 X | |||
| Price To Sales | 1.07 X | |||
| Revenue | 277.87 M | |||
| Gross Profit | 63.24 M | |||
| EBITDA | 43.72 M | |||
| Net Income | 18.83 M | |||
| Cash And Equivalents | 24.94 M | |||
| Cash Per Share | 0.28 X | |||
| Total Debt | 116.57 M | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 1.02 X | |||
| Book Value Per Share | 2.92 X | |||
| Cash Flow From Operations | 36.31 M | |||
| Earnings Per Share | 0.25 X | |||
| Number Of Employees | 1.86 K | |||
| Beta | 0.54 | |||
| Market Capitalization | 333.64 M | |||
| Total Asset | 626.51 M | |||
| Z Score | 1.2 | |||
| Net Asset | 626.51 M |
About Garofalo Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Garofalo Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Garofalo Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Garofalo Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Garofalo Stock
Garofalo Health financial ratios help investors to determine whether Garofalo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Garofalo with respect to the benefits of owning Garofalo Health security.